Multicenter Analysis of Anidulafungin Use in Invasive Candida Infections
| Autor: | Dilek Yeşim Metin, Çağri Ergin, Murat Kutlu, Özge Turhan, Mustafa Bülent Ertuğrul, Vildan Avkan Oğuz, Oya Özlem Eren Kutsoylu, Nur Yapar, Betil Özhak, Barcin Ozturk, Hüsnü Pullukçu, Meltem Taşbakan, Çiğdem Banu Çetin, Selda Sayin Kutlu, Sema Alp Çavuş, Gülşen Mermut, Onur Kaya, Şebnem Şenol Akat |
|---|---|
| Jazyk: | angličtina |
| Rok vydání: | 2019 |
| Předmět: | |
| Zdroj: | Flora Infeksiyon Hastalıkları ve Klinik Mikrobiyoloji Dergisi, Vol 24, Iss 2, Pp 136-142 (2019) |
| Popis: | Introduction: Fungal infections are vital problems worldwide and their incidence have increased along with changing patient profile. Particularly candida species is still the most commonfungal agent, and the significance of non-albicans candida species have gained importance in recent years. In the present study, it was aimed to evaluate retrospectively the risk factors and distribution of candida species in patients with invasive candida infections, who were treated with anidulafungin. Materials and Methods: In the first three years (1 January 2012 to 31 December 2014) when anidulafungin came out in our country, we retrospectively evaluated the data of the patients with invasive candida infections who were treated by anidulafungin for more than 48 hours in seven university hospitals. Data were recorded to the case report forms. Results: Two hundreds and fifty-seven patients were included into the study. Fifty-six percent of the patients were male and mean age was 58.57 +/- 19.5 years. Two hundreds and three patients (79%) were hospitalized in intensive care units, 37 (14.3%) in internal medicine services, and 17 (0.07%) in surgery services. As previously described, we detected antibiotic usage in the last month (%96.9), presence of urinary catheter (90.3%) and presence of central venous catheter (82.1%) as risk factors for invasive candida infections. More than half of the patients (57.1%) with central venous catheter had candidemia. Sixty-six (47.7%) of the blood isolates were Candida albicans, 33 (23.7%) were Candida parapsilosis, 17 (12.2%) were Candida tropicalis and 13 (9.4%) were Candida glabrata. During follow up, 64.5% of 124 patients whose catheters couldn't be taken off and 47.6% of 86 patients whose catheters could be taken off died. During anidulafungin treatment, one anaphylaxis, one skin eruption and one thrombocytopenia were seen as side effects. Conclusion: In our study, we found that removal of central venous catheter of the patients with candidemia was a positive effect on mortality. We suggest that patients with candidemia, insisting on catheter removal besides antifungal treatment is necessary. We observed that anidulafungin is an effective and safe choice in invasive candida infections. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|